Special Sessions
Monday, March 27th
11:00-12:00 - Morgiou
S1: Social Media Session
Chairs: Naveen Pemmaraju, USA - @doctorpemm; Navneet Majhail, USA - @BldCancerDoc &
Mélanie Chaboissier, Spain - @TheEBMT
11:00-11:10 Everything you need to know about Twitter: Navneet Majhail, USA
11:10-11:30 Social Media and the Adolescent and Young Adult cancer community: Naveen Pemmaraju, USA
11:30-11:50 Social Media for connecting doctors: the Myeloproliferative neoplasms (MPNs) model #mpnsm:
Naveen Pemmaraju, USA
11:50-12:00 Discussion with the audience and the panel of Twitter ambassadors
Tuesday, March 28th
09:00-10:30 - Endoume 1
S2: How to get published?
09:00-10:30 How to get published (in collaboration with NPG): Junia Melo, Australia
11:00-12:30 - Podestat
S3: Access to innovations: the pharma-academia partnership
Chairs: Dominique Maraninchi, France; Catherine Bollard, USA & Mohamad Mohty, France
11:00-11:15 Evaluations of novel drugs across Europe: Jean-Luc Harousseau, France
11:15-11:30 Access to innovation and economic issues: Challenges for the French national authority for health (HAS):
Agnès Buzyn, France
11:30-11:45 Innovation from bench to bedside: Claudio Bordignon, Italy
11:45-12:00 The pharma perspective: Emmanuelle Quilès, France
12:00-12:30 Debate with the audience: Chairs and speakers
14:00-16:00
Statistical Symposium - Podestat
Chairs: Hein Putter, The Netherlands & Simona Iacobelli, Italy
14:00-14:30 Methodology in relative survival: Maja Pohar Perme, Slovenia
14:30-15:00 Relative Survival: An application on EBMT data: Ariane Boumendil, France
15:00-15:30 Evaluating the benefit of HCT - propensity score versus genetic randomization: Sylvie Chevret, France
15:30-16:00 Interval censoring: some problems and some solutions: Karen Leffondré, France
14:30-15:30 - Hall 1
S4: Continuous medical education for transplant physicians
Chairs: Mohamad Mohty, France & André Tichelli, Switzerland
14:30-14:50 JACIE requirements: Riccardo Saccardí, Italy
14:50-15:10 Accreditation in medical education: the view from the EBAH: André Tichelli, Switzerland
15:10-15:30 EBMT initiative: Nicolaus Kröger, Germany
16:30-18:00 - Auditorium
Chairs: Mohamad Mohty, France & Christian Chabannon, France
16:30-17:00 Honorary and Clinical Achievement awards
Awardees:
Dean Buckner, Honorary
Alex R. Zander, Honorary
Dominique Maraninchi, Clinical Achievement
Ljiljana Tukic, Clinical Achievement
17:00-17:10 The UM171 Cord Blood Expansion Trial: Smaller, Better HLA Matched Cords in Short 7 Day Fedbatch Cultures
Already Provide Clinical and Cost Benefits: Sandra Cohen, Canada
17:10-17:20 Letermovir (LET) for prevention of cytomegalovirus (CMV) infection: Results from a Phase III randomized, double-
blind, placebo (PBO)-controlled trial in adult allogeneic hematopoietic cell transplant (alloHCT) recipients:
Per Ljungman, Sweden
17:20-17:30 Myeloablative autologous transplantation of CD343+_ selected hematopoietic stem cells vs. monthly intravenous
cyclophosphamide for severe scleroderma with internal organ involvement: Outcomes of the randomized
scleroderma: Cyclophosphamide or transplantation (SCOT) trial: Keith Sullivan, USA
17:30-17:40 Application of the disease risk index for risk stratification of allogeneic hematopoietic stem cell transplantation in a
large cohort of the European Society for Blood and Marrow Transplantation (EBMT): Roni Shouval, Israel
17:40-17:50 Fecal microbiota transplantation in patients with blood disorders inhibits gut colonization with antibiotic-resistant
bacteria: Results of a prospective, single-center study: Grzegorz Basak, Poland
17:50-18:00 Inotuzumab ozogamicin (InO) vs. Standard of care (SC) for relapsed/refractory (R/R) acute lymphoblastic leukemia
(ALL) in the Phase 3 INOVATE Trial: Outcomes in patients who received post-study hematopoietic stem cell
transplantation (HSCT): David Marks, USA
18:00-18:30 - Auditorium
GA: General Assembly
Chairs: Mohamad Mohty, France & Rafael Duarte, Spain
Outgoing Award recognitions presented by Mohamad Mohty
-Rafael Duarte, Outgoing Working Party Chair
-Andrew Gennery, Outgoing Working Party Chair
-Aleksandra Babic, Outgoing Nurses Group President
Wednesday, March 29th
09:00-10:30 - Les Goudes 1
S6. EBMT global collaborations: East and West raising the bar together
Chairs: Mohamad Mohty, France; Arnon Nagler, Israel & Christian Chabannon, France
09:00-09:15 The Australian perspective: David Gottlieb, Australia
09:15-09:30 The Chinese perspective: Xiao-jun Huang, China
09:30-09:45 The Indian perspective: Lalit Kumar, India
09:45-10:00 The Japanese perspective: Life after transplantation: Shinichiro Okamoto, Japan
10:00-10:15 The Latin American perspective: Raúl Gabus, Uruguay
10:15-10:30 Round table discussion: Speakers and chairs
11:00-12:30 - Endoume 1
S7: The best clinical trials of the year
Chairs: Mohamad Mohty, France & Christian Chabannon, France
11:00-11:15 It is moving fast: Christian Chabannon, France
11:15-11:30 First in class and revolutionary: Mohamad Mohty, France
11:30-11:45 Let's reset the system: Riccardo Saccardí, Italy
11:45-12:00 Two novel options: Arnon Nagler, Israel
12:00-12:15 Please keep an eye on the checkpoints: Ali Bazarbachi, Lebanon